Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00014291
DRKS00014291
Completed
未知

Relevance of DNIC (diffuse noxious inhibitory Control) for pain and hyperalgesia following an incision in healthy volunteers. - Incision CPM Study

niversitätsklinikum Münster, Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie0 sites24 target enrollmentMarch 16, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsENDOGENESCHMERZHEMMUNGUNDSENSITISIERUNGDIEZUAKUTEUNDCHRONSICHESCHMERZENFHRENKNNE

Overview

Phase
未知
Intervention
Not specified
Conditions
ENDOGENESCHMERZHEMMUNGUNDSENSITISIERUNGDIEZUAKUTEUNDCHRONSICHESCHMERZENFHRENKNNE
Sponsor
niversitätsklinikum Münster, Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie
Enrollment
24
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 16, 2018
End Date
December 15, 2010
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
niversitätsklinikum Münster, Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie

Eligibility Criteria

Inclusion Criteria

  • •healthy, male volunteers

Exclusion Criteria

  • •Patients under 18 years of age, intake of analgesics or psychopharmaca, chronic pain condition, neurological condition, diabetes mellitus, hypertension

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Farmakologisk behandling af CNDI – Et ”proof-of-concept” studie. - NDI-POC-STUDYKongenit nefrogen diabetes insipidusMedDRA version: 14.1Level: PTClassification code 10068304Term: Congenital nephrogenic diabetes insipidusSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2006-003360-56-DKDept. of Pediatrics, The Childrens Hospital, Denver40
Completed
Not Applicable
Diffuse noxious inhibitory controls in chronic cough
ISRCTN31901405niversity Hospitals of South Manchester NHS Foundation Trust (UK)40
Recruiting
Not Applicable
Treating shrinking of lungs
CTRI/2011/11/002150Institute of Pulmocare Research60
Not yet recruiting
Phase 4
A study to see the analgesic and safety efficacy of Tab. Diclofenac sodium and Tab. EtodolacHealth Condition 1: null- Patient with surgical removal of third molar tooth
CTRI/2016/11/007437Sir Takhtsinhaji General Hospital and Government Medical College Bhavnagar100
Not yet recruiting
Not Applicable
Clinical investigation of the effectiveness of different mouth rinses in Covid-19-PatientsCOVID-19
DRKS00023725niversität Witten/Herdecke Fakultät für Gesundheit (Department für Zahn-, Mund- und Kieferheilkunde)Lehrstuhl für Zahnerhaltung und Präventive Zahnmedizin60